Recipiente de evaporación ROTILABO® con fondo plano, 15 ml, 10 Unidad(es)

tert-Butyl 5-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate, 95.0%, 250mg

Ethyl 4-Iodophenylacetate, 98.0%, 5g

8-Hydroxy-1,1,7,7-tetramethyljulolidine-9-carboxaldehyde, 98.0%, 250mg

1,3,7-TRIAZA-SPIRO[4.5]DECANE-2,4-DIONE, 95.0%, 25g

5-chloro-2,4-dihydro-3H-1,2,4-triazol-3-one, 95.0%, 1g

3-Bromo-1-methyl-4-nitro-1H-pyrazole, 97.0%, 5g

4-chloro-6-(2-thienyl)pyrimidine, 95.0%, 1g

GOLVATINIB, 95%, 100mg

7-Amino-5-methyl-5H-dibenzo[b,d]azepin-6(7H)-one hydrochloride, 98%, 250mg

(E)-3-(dimethylamino)-2-phenylmethoxyprop-2-enal, 97%, 500mg

2,4-Dichloro-5-iodo-7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidine, 98%, 5g

cis-4-(Hydroxymethyl)cyclohexanecarboxylic Acid>98.0%(GC)1g